Drug Shortage Report for SANDOZ OMEPRAZOLE

Last updated on 2024-04-03 History
Report ID 215347
Drug Identification Number 02296446
Brand name SANDOZ OMEPRAZOLE
Common or Proper name OMEPRAZOLE
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) OMEPRAZOLE
Strength(s) 20MG
Dosage form(s) CAPSULE (DELAYED RELEASE)
Route of administration ORAL ORAL
Packaging size 500GRC
ATC code A02BC
ATC description DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2024-01-08
Estimated end date Unknown
Actual end date 2024-04-02
Shortage status Resolved
Updated date 2024-04-03
Company comments Discontinued
Health Canada comments
Tier 3 Status No
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v8 2024-04-03 English Compare
v7 2024-04-02 French Compare
v6 2024-04-02 English Compare
v5 2024-01-15 French Compare
v4 2024-01-15 English Compare
v3 2024-01-09 English Compare
v2 2024-01-08 French Compare
v1 2024-01-08 English Compare

Showing 1 to 8 of 8